Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,459 signal articles · 150 in last 24h · 154,156 total before filter · latest 53m ago
150last 24h
877last 7d
146● bullish (7d)
96● bearish (7d)
214publishers
AllMacro212Earnings108M&A125Regulatory21Product21Analyst17
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Elon Musk Is Teasing a Tesla-SpaceX Merger Again. Terafab Shows Why AI Could Be the Logic
Insider Monkey1d agoneutral
Elon Musk Is Teasing a Tesla-SpaceX Merger Again. Terafab Shows Why AI Could Be the Logic

Elon Musk has reopened a question investors have kicked around for years: why keep Tesla and SpaceX separate if more of their technology is beginning to converge? During the September 15 All-In Podcast, Musk joined SpaceX President Gwynne Shotwell for a discussion that explicitly included Terafab and the possibility of combining the two companies. Tesla, […]

Why Is Lowe's (LOW) Eyeing Tuck In Acquisitions As It Pursues Growth?
Simply Wall St.1d agoneutral
Why Is Lowe's (LOW) Eyeing Tuck In Acquisitions As It Pursues Growth?

Lowe's Companies (NYSE:LOW) signaled interest in future tuck-in acquisitions as part of its growth plans. Management framed potential deals as incremental additions that would fit within the existing Lowe's operating model. Executives paired the acquisition comments with an emphasis on disciplined capital allocation and balance sheet priorities. The fresh focus on tuck-in acquisitions is only one piece of the Lowe's Companies story investors need to understand. Check out 2 warning signs (1...

Cognex Acquires RealSense for $500M to Expand Robotic Vision Platform
MarketBeat2d agoneutral
Cognex Acquires RealSense for $500M to Expand Robotic Vision Platform

Cognex (NASDAQ:CGNX) said it has entered into a definitive agreement to acquire RealSense, a provider of depth-sensing cameras and vision technology used in robotic perception and physical AI applications. The transaction is intended to expand Cognex’s machine-vision portfolio into 3D depth percept

TTM Technologies (TTMI) Is Up 9.5% After Debt-Funded AI and Defense Acquisition Push Announcement
Simply Wall St.2d agoneutral
TTM Technologies (TTMI) Is Up 9.5% After Debt-Funded AI and Defense Acquisition Push Announcement

In September 2026, TTM Technologies completed a US$500 million private offering of 6.750% senior unsecured notes due 2034, supported by incremental term loans, to help finance its planned acquisitions of Epiq Solutions and Swiss Technology Group and cover related corporate purposes, with a conditional redemption feature if Epiq Solutions is not acquired by the agreed outside date. By pairing this financing activity with a presence at Electronica India 2026 in Bengaluru, the company signaled...

Investing.com2d agoneutral
Exclusive: SB Energy Nasdaq IPO moving forward as planned

Investing.com -- SB Energy’s multi-billion-dollar initial public offering is advancing according to plan, a person familiar with the matter told Investing.com, dispelling reports of a delay. However, the source did not explicitly state when the IPO would take place, noting only that internal preparations are proceeding as intended. The clarification follows SB Energy’s amended S-1 filing with the U.S. Securities and Exchange Commission (SEC) yesterday, which confirmed that preparations for listi

SpaceX (SPCX) Stock Looks Rich On Fresh Merger Speculation
Simply Wall St.2d agoneutral
SpaceX (SPCX) Stock Looks Rich On Fresh Merger Speculation

Space Exploration Technologies has climbed 10.9% over the past month, putting fresh attention on whether a book value lens still lines up with where the stock trades today. With the share price at US$151.85 and fresh headlines around contracts, AI ambitions and possible tie ups, the question for many investors is how much of the balance sheet is already priced in. The 10.9% gain over the last 30 days raises the stakes for anyone asking whether recent momentum in Space Exploration...

What Johnson & Johnson (JNJ)'s Bipolar I Mania Data for CAPLYTA Means For Shareholders
Simply Wall St.2d agoneutral
What Johnson & Johnson (JNJ)'s Bipolar I Mania Data for CAPLYTA Means For Shareholders

Johnson & Johnson recently reported positive topline Phase 3 results for CAPLYTA (lumateperone) in adults with bipolar I disorder experiencing manic episodes, showing rapid and statistically significant symptom reduction versus placebo, while also highlighting progress across its broader neuropsychiatry portfolio. The data suggest CAPLYTA could potentially treat both depressive and acute manic episodes in bipolar I disorder, meaningfully broadening its clinical role if future regulatory...